Federal ban on gender care for minors opens doctors to 25-year retroactive lawsuits.

What it does

This bill prohibits healthcare professionals, hospitals, and clinics from providing puberty blockers, sex hormones, or gender-affirming surgeries to minors under 18, defining these treatments as 'chemical or surgical mutilation.' It creates a federal private right of action allowing individuals and parents to sue providers for damages—including compensatory, non-economic, and punitive damages—for up to 25 years after the patient turns 18, with strict liability for violations and a broad jurisdictional hook based on interstate commerce.

Why we flagged it

The bill's core mechanism is a federal prohibition on gender-affirming medical treatments for minors, coupled with a private right of action that applies retroactively to treatments provided before enactment. This is not primarily a medical-safety or child-protection measure in the conventional sense—it is a categorical ban on a class of treatments, enforced through civil liability rather than regulatory oversight.

What the text implies

• Retroactive liability (Section 4) exposes healthcare providers to lawsuits for treatments performed before the bill's enactment, potentially decades after the fact, under standards that did not exist at the time of treatment. This creates legal jeopardy for conduct that was lawful and aligned with prevailing medical standards when performed.
• The 'clear and convincing evidence' standard for exceptions (Section 3) and the burden-shifting rule (Section 4) place the evidentiary weight on defendants to prove medical necessity, inverting the usual presumption that lawful medical practice is valid unless proven harmful.

The full analysis lists 5 implications of this text.

Who stands to gain

litigation funders and plaintiff's attorneys (contingency-fee class actions); medical malpractice insurers (increased claims and premiums)